Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Minneapolis Article
This is a selection made from among articles on Drug Treatment Minneapolis. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Drug Rehab and Dual Diagnosis Treatment For You
By Jonathan Huttner
Dual Diagnosis Information Dual diagnosis means that a person has two different illnesses. They have a mental health or behavioral condition, and they also have an addiction or a substance abuse problem. Dual diagnosis is going to take a toll on much more than just the parts of a person’s life that are affected by drug abuse and alcohol abuse.
Dual diagnosis is something that many people have. Studies have shown that almost half of the people who have an drug addiction will also have a mental health issue as well. When an addiction treatment center only deals with drug addiction, and fails to deal with the actual mental health issues, the mental health problems are going to lead right back to addiction after the person has been in recovery. This happens more often than we are aware of, and it could be one of the biggest contributors to chronic relapse.
When it comes right down to it, mental health and addiction issues should be treated together. If you have gone through addiction treatment and have gone back to using, you might have a mental health condition that is preventing you from getting any better. Perhaps there is depression, or other mental health issues that are keeping you from staying on the path to recovery. If you are looking for an addiction treatment program capable of effectively treating dual diagnosis you might try www.lakeviewhealth.com or go to www.steppingstonecenter.org For additional information on dual diagnosis, mental health issues, drug addiction or alcoholism go to www.dual-diagnosis-treatment-center.com
Jonathan Huttner is a principal with lakeview Health Systems, a dual diagnosis treatment center with specialty programs for the GLBT and Hispanic community.
Article Source: http://EzineArticles.com/?expert=Jonathan_Huttner
http://EzineArticles.com/?Drug-Rehab-and-Dual-Diagnosis-Treatment-For-You&id=458062
Drug Treatment Minneapolis Specific links
Drug Treatment Minneapolis News
Medtronic Hypertension Burning Seen as Spurring Industry - BusinessWeek
Medtronic Hypertension Burning Seen as Spurring Industry BusinessWeek And even those who are helped by drug treatment may eventually benefit from the procedure. Medtronic, based in Minneapolis, and its rivals may generate $1.5 billion to $4.4 billion annually depending on the medical conditions the devices successfully ... |
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients ... - MarketWatch (press release)
 Angioplasty.Org | Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients ... MarketWatch (press release) MINNEAPOLIS, May 25, 2012 (BUSINESS WIRE) -- According to study results to be featured in Sunday's late-breaking clinical trials session at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in ... Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients ... |
Doctors experimenting with new invasive approach for hypertension - Marietta Daily Journal
Doctors experimenting with new invasive approach for hypertension Marietta Daily Journal Most need multiple drugs to treat it. Some 10 percent, more than 7 million people like Ezzell, have the resistant hypertension that is the initial target of the nerve-zapping procedure _ people with high blood pressure despite three or more different ... |
CORRECTING and REPLACING Medtronic IN.PACT Drug-Eluting Balloon Studies Show ... - MarketWatch (press release)
CORRECTING and REPLACING Medtronic IN.PACT Drug-Eluting Balloon Studies Show ... MarketWatch (press release) PACT drug-eluting balloon from Medtronic, Inc. (NYSE:MDT) over a corresponding conventional treatment for coronary and peripheral artery disease, respectively. Medtronic IN.PACT drug-eluting balloons received CE (Conformite Europeenne) mark in 2008 and ... |
Long Term Treatment of Symptomatic BPH with Potentially Harmful Drugs Should ... - San Francisco Chronicle (press release)
Long Term Treatment of Symptomatic BPH with Potentially Harmful Drugs Should ... San Francisco Chronicle (press release) Long term drugs may reduce the risk of BPH complications such as acute urinary retention but can cause one or more side effects and new Thermobalancing Therapy provides a natural prostate cure that is free from negative health effects, Fine Treatment ... |
Feds close probe into Medtronic's Infuse spinal treatment - Pioneer Press
Feds close probe into Medtronic's Infuse spinal treatment Pioneer Press In 2008, the Food and Drug Administration issued a public health warning that cautioned doctors against using Infuse in ways not described on the FDA-approved label for the product. Also that year, a federal whistleblower lawsuit questioned whether ... |
Children with Cancer Have Complete Responses in a Children's Oncology Group ... - MarketWatch (press release)
Children with Cancer Have Complete Responses in a Children's Oncology Group ... MarketWatch (press release) Because drug manufacturers had already developed crizotinib for use in adult lung cancer clinical trials, Mosse and colleagues were able to quickly move crizotinib into an initial pediatric trial. "We are entering a new era of cancer therapy, ... |
Back where it started: addiction on campus - Minnesota Daily
Back where it started: addiction on campus Minnesota Daily Coping with addiction, three college dropouts are now at the University of Minnesota, trying to find the resources to prevent a relapse in the culture where their problems started. Cody Lake, right, and roommate Nick Fehst smoke a cigarette on the ... |
Medspira Receives FDA 510K Clearance for mcompass Anorectal Manometry Device - DOTmed.com
Medspira Receives FDA 510K Clearance for mcompass Anorectal Manometry Device DOTmed.com Minneapolis - Medspira has received US Food and Drug (FDA) 510K clearance for its innovative mcompass anorectal manometry device. Anorectal manometry testing evaluates pelvic floor function in patients with constipation or fecal incontinence. |
New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving ... - MarketWatch (press release)
New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving ... MarketWatch (press release) Last month, the US Food & Drug Administration (FDA) approval expanded the indication for Medtronic's CRT-D devices to treat NYHA Class II heart failure patients with a left ventricular ejection fraction (LVEF) of less than or equal to 30 percent, ... |